Nonmedical prescribing in the United kingdom: developments and stakeholder interests.
This article reflects upon the introduction of nonmedical prescribing in the United Kingdom and describes the historical developments within the National Health Service over the last 2 decades, together with an assessment of the impact of this prescribing for various stakeholders, drawing upon relevant research. We argue that a number of issues are associated with the introduction and development of nonmedical prescribing, including benefits to patients, the promise of increased autonomy for professions such as nursing and pharmacy, explicit and implicit government objectives, and threats to medical dominance and autonomy.
Division of Social Research in Medicines and Health, School of Pharmacy, University of Nottingham, United Kingdom.
Richard
R
Cooper
Louise
L
Guillaume
Tony
T
Avery
Claire
C
Anderson
Paul
P
Bissell
Allen
A
Hutchinson
Joanne
J
Lymn
Elizabeth
E
Murphy
Paul
P
Ward
Julie
J
Ratcliffe
D003153:Community Health Services / Q000639:trends; D011307:Drug Prescriptions / Q000266:history / Q000451:nursing; D018166:Health Care Reform; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D007880:Legislation, Drug / Q000266:history; D009726:Nurses; D010595:Pharmacists; D024382:Professional Role; D013222:State Medicine / Q000266:history / Q000331:legislation & jurisprudence* / Q000639:trends; D006113:United Kingdom